Question special

The Food and Drug Administration (FDA) has approved the use of investigational COVID-19 convalescent plasma for treatment of patients with COVID-19. The use of convalescent plasma- collected from patients who have had a disease and recovered- has been studied in outbreaks past and is the focus of new hope for a breakthrough in the COVID-19 pandemic. Do you know of any cases where this investigational therapy is being used in your hospital setting?